1. Today's research, tomorrow's health: focus on pharmacogenomics
- Author
-
Megan E. Kozisek, David B. Bylund, Megan D. Montgomery, and Abbey L. Reed
- Subjects
Pharmacology ,medicine.medical_specialty ,business.industry ,Alternative medicine ,Citizen journalism ,General Medicine ,Medical research ,Focus (linguistics) ,Pharmacogenomics ,medicine ,Molecular Medicine ,Experimental biology ,Engineering ethics ,Personalized medicine ,business ,Theme (narrative) - Abstract
Many of the scientific societies belonging to the Federation of American Societies for Experimental Biology meet together each spring under the umbrella of the Experimental Biology meeting. This year’s meeting was attended by over 11,000 scientists (total registration was 13,428) and included six sponsoring societies (American Society for Pharmacology and Experimental Therapeutics, American Physiological Society, American Society for Biochemistry and Molecular Biology, American Society for Investigative Pathology, American Society for Nutrition and American Association of Anatomists) as well as 18 guest societies. Of particular interest to the readers of this journal are the ten symposia in the Pharmacogenomics Theme programmed by the American Society for Pharmacology and Experimental Therapeutics, as well as at least five additional symposia programmed by other participating societies. The titles of these symposia are listed in Box 1. This report will comment on six of these symposia. The tone for the meeting was set by Elias Zerhouni, Director of the NIH, in his talk entitled ‘NIH: Challenges and Opportunities in Science’. He reviewed the need to transform medical research in the twenty-first century to make it possible to intervene before symptoms appear, based on an understanding of preclinical molecular events. He then presented ‘The Future Paradigm’ with the four Ps of the transformation of medicine from curative to preemptive: participatory, predictive, personalized and preemptive [101]. “This requires patient involvement well before disease strikes. As opposed to the doctor-centric, curative model of the past, the future is going to be patient-centric and proactive. It must be based on education and communication.” As can be seen from Figure 1, personalized medicine is central to this needed transformation. Pharmacogenomics will be a important aspect of the transformation.
- Published
- 2018